文献速递急性肾损伤遗传性与小管间质肾病

丙酮酸脱氢酶激酶4缺失减轻顺铂诱导的急性肾损伤

Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
PubMed 文献 · Kidney Int · 2016-12-28

在小鼠模型中,顺铂使肾脏PDK4的mRNA和蛋白水平明显升高,c-Jun N末端激酶激活参与该过程;使用PDK抑制剂二氯乙酸钠或敲除PDK4可减轻顺铂诱导的急性肾损伤、改善线粒体功能并减少氧化应激和脂质蓄积。

要点

  • 顺铂使小鼠肾脏PDK4的mRNA和蛋白水平明显升高。
  • 二氯乙酸钠或敲除PDK4可减轻顺铂诱导的肾小管损伤。
  • PDK4可能成为减轻顺铂肾毒性的治疗靶点。

核心结论

  • PDK4介导顺铂诱导的急性肾损伤,提示PDK4可能是减轻顺铂诱导的急性肾损伤的治疗靶点。

研究设计与样本

  • 研究为小鼠实验,比较顺铂处理后的肾脏PDK4表达,并采用PDK抑制剂二氯乙酸钠处理或PDK4基因敲除观察对顺铂诱导的急性肾损伤的影响。

主要发现

  • 顺铂处理小鼠肾脏PDK4的mRNA和蛋白水平明显升高,c-Jun N末端激酶激活参与顺铂诱导的肾脏PDK4表达。
  • 二氯乙酸钠处理或PDK4敲除减轻顺铂诱导的急性肾损伤表现,包括肾小管凋亡形态、TUNEL阳性细胞数、cleaved caspase-3和肾小管损伤标志物。
  • 二氯乙酸钠处理或PDK4敲除小鼠肾脏中,顺铂诱导的线粒体膜电位抑制、氧消耗率、电子传递链组分表达、细胞色素c氧化酶活性和线粒体形态破坏均明显改善。
  • 二氯乙酸钠处理或PDK4敲除小鼠中,氧化应激标志物4-羟基壬烯醛和线粒体活性氧水平降低,超氧化物歧化酶2和过氧化氢酶表达及谷胱甘肽合成酶和谷胱甘肽水平恢复。
  • 二氯乙酸钠处理或PDK4敲除小鼠中脂质蓄积明显减轻,伴过氧化物酶体增殖物激活受体α和共激活因子PGC-1α表达恢复及线粒体生物合成恢复。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical prescription of cisplatin, one of the most widely used chemotherapeutic agents, is limited by its side effects, particularly tubular injury-associated nephrotoxicity. Since details of the underlying mechanisms are not fully understood, we investigated the role of pyruvate dehydrogenase kinase (PDK) in cisplatin-induced acute kidney injury. Among the PDK isoforms, PDK4 mRNA and protein levels were markedly increased in the kidneys of mice treated with cisplatin, and c-Jun N-terminal kinase activation was involved in cisplatin-induced renal PDK4 expression. Treatment with the PDK inhibitor sodium dichloroacetate (DCA) or genetic knockout of PDK4 attenuated the signs of cisplatin-induced acute kidney injury, including apoptotic morphology of the kidney tubules along with numbers of TUNEL-positive cells, cleaved caspase-3, and renal tubular injury markers. Cisplatin-induced suppression of the mitochondrial membrane potential, oxygen consumption rate, expression of electron transport chain components, cytochrome c oxidase activity, and disruption of mitochondrial morphology were noticeably improved in the kidneys of DCA-treated or PDK4 knockout mice. Additionally, levels of the oxidative stress marker 4-hydroxynonenal and mitochondrial reactive oxygen species were attenuated, whereas superoxide dismutase 2 and catalase expression and glutathione synthetase and glutathione levels were recovered in DCA-treated or PDK4 knockout mice. Interestingly, lipid accumulation was considerably attenuated in DCA-treated or PDK4 knockout mice via recovered expression of peroxisome proliferator-activated receptor-α and coactivator PGC-1α, which was accompanied by recovery of mitochondrial biogenesis. Thus, PDK4 mediates cisplatin-induced acute kidney injury, suggesting that PDK4 might be a therapeutic target for attenuating cisplatin-induced acute kidney injury.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Oh CJ, Ha CM, Choi YK, et al. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury. Kidney Int. 2016. PMID: 28040265. doi:10.1016/j.kint.2016.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。